Insight
New rare disease platform launched for Hunter Syndrome
Hunter syndrome (MPS II) is a rare condition resulting from mutations in the gene that codes for the production of the lysosomal enzyme iduronate-2-sulfatase (I2S). Recognition and diagnosis at an early stage is crucial to establishing appropriate management strategies.
Please note the Hunter Syndrome Knowledge Centre is not intended for HCPs in USA or UK. It has been developed by EPG Health for Medthority.com, in collaboration with Shire.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins